COCP: Cocrystal Pharma, Inc. Stock

by  •  • Comments Off on COCP: Cocrystal Pharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 21.98
Enterprise Value ($M) 8.96
Book Value ($M) 12.70
Book Value / Share 1.25
Price / Book 1.73
NCAV ($M) 10.73
NCAV / Share 1.05
Price / NCAV 2.05

Profitability (mra)
Return on Invested Capital (ROIC) -1.28
Return on Assets (ROA) -0.57
Return on Equity (ROE) -0.61

Liquidity (mrq)
Quick Ratio 7.32
Current Ratio 7.32

Balance Sheet (mrq) ($M)
Current Assets 14.26
Assets 16.23
Liabilities 3.53
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Beore Dividends Basic n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-02 13G/A Sabby Management, Llc 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-04-17 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 1,502 14,940 10.05
2024-11-21 6,726 18,605 36.15
2024-11-20 4,013 11,519 34.84
2024-11-19 1,147 11,677 9.82

(click for more detail)

Similar Companies
CMPX – Compass Therapeutics, Inc. CNSP – CNS Pharmaceuticals, Inc.
CNTX – Context Therapeutics Inc. COEP – Coeptis Therapeutics Holdings, Inc.
CORT – Corcept Therapeutics Incorporated


Financial data and stock pages provided by
Fintel.io